Scott A. Kelly - Oct 18, 2021 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
Chairman & CMO, Director
Signature
Michael D. Mulholland, Attorney-In-Fact
Stock symbol
CYDY
Transactions as of
Oct 18, 2021
Transactions value $
$0
Form type
4
Date filed
10/20/2021, 04:20 PM
Previous filing
Aug 10, 2021
Next filing
Jun 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified Stock Option Award $0 +1.75M $0.00 1.75M Oct 18, 2021 Common Stock 1.75M $1.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in 3 equal annual installments beginning on August 6, 2022, subject to Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.